Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Not to Sound like a Broken Record
If this is true I wonder why the compensation packages for Pohl and the Board are given other than to reward themselves and not shareholders.  My impression from the shareholder meeting is that TPL tells Patriot what they want them to know.  Very disappointed with this investment.
Share
New Message
Please login to post a reply